Windlas Biotech Ltd (WINL)

Currency in INR
985.55
+10.95(+1.12%)
Closed·
WINL Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
WINL is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
965.001,013.60
52 wk Range
665.101,198.25
Key Statistics
Bid/Ask
985.55 / 989.00
Prev. Close
985.55
Open
977.35
Day's Range
965-1,013.6
52 wk Range
665.1-1,198.25
Volume
105.26K
Average Volume (3m)
54.68K
1-Year Change
35.32%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
WINL Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Has raised its dividend for 4 consecutive years

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Windlas Biotech Ltd Company Profile

Windlas Biotech Limited, a contract development and manufacturing organization, manufactures and trades in pharmaceutical products in India. The company offers contract manufacturing; customized formulations; contract research and manufacturing services; customized formulation; and regulatory services. It also manufactures tablets, capsules, oral solids, modified-release formulations, chewable and dispersible tablets, customized generics, and complex generics and multi-drug combinations, as well as injectables, including liquid vials, lyophilized vials, and ampoules. In addition, the company offers generic drugs for respiratory, anti-diabetic, gastroenterology, cardiovascular and multivitamin, neuro anti-psychotic, diabetic care, nutraceuticals, nutritional supplement, urology, pain management, and injectable therapies. It also exports generic medicines, health supplements, and custom-branded formulations. Windlas Biotech Limited was incorporated in 2001 and is headquartered in Dehradun, India.

0
Market
India

Compare WINL to Peers and Sector

Metrics to compare
WINL
Peers
Sector
Relationship
P/E Ratio
33.8x39.0x−0.5x
PEG Ratio
9.510.410.00
Price/Book
4.1x5.4x2.6x
Price / LTM Sales
2.7x6.1x3.2x
Upside (Analyst Target)
-0.7%41.6%
Fair Value Upside
Unlock−11.3%6.0%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 29.19%
Dividend Yield
0.59%
Industry Median 0.74%
Annualised payout
5.80
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 22, 2025
EPS / Forecast
7.69 / --
Revenue / Forecast
2.08B / --
EPS Revisions
Last 90 days

WINL Income Statement

People Also Watch

967.65
NATP
-3.14%
84.19
MAGL
+0.20%
2,145.30
GLEN
+0.05%
6,062.00
TTEX
-2.63%

FAQ

What Stock Exchange Does Windlas Biotech Trade On?

Windlas Biotech is listed and trades on the India National Stock Exchange stock exchange.

What Is the Stock Symbol for Windlas Biotech?

The stock symbol for Windlas Biotech is "WINL."

What Is the Windlas Biotech Market Cap?

As of today, Windlas Biotech market cap is 20.60B.

What Is Windlas Biotech's Earnings Per Share (TTM)?

The Windlas Biotech EPS (TTM) is 29.19.

From a Technical Analysis Perspective, Is WINL a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Windlas Biotech Stock Split?

Windlas Biotech has split 0 times.

How Many Employees Does Windlas Biotech Have?

Windlas Biotech has 0 employees.

What is the current trading status of Windlas Biotech (WINL)?

As of 27 Jul 2025, Windlas Biotech (WINL) is trading at a price of 985.55, with a previous close of 985.55. The stock has fluctuated within a day range of 965.00 to 1,013.60, while its 52-week range spans from 665.10 to 1,198.25.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.